#METABOLOMICS WORKBENCH ehiggins_20221217_122538 DATATRACK_ID:3656 STUDY_ID:ST002449 ANALYSIS_ID:AN003997 PROJECT_ID:PR001064
VERSION             	1
CREATED_ON             	January 20, 2023, 11:24 am
#PROJECT
PR:PROJECT_TITLE                 	Volatile Biomarkers for a Valley Fever Breath Test
PR:PROJECT_TYPE                  	GCxGC-TOFMS metabolomics
PR:PROJECT_SUMMARY               	Coccidioidomycosis, or valley fever, is prevalent in AZ, with more than 12,000
PR:PROJECT_SUMMARY               	new human infections diagnosed every year. In highly endemic areas, e.g.,
PR:PROJECT_SUMMARY               	Phoenix and Tucson, up to 30% of community-acquired pneumonia may be caused by
PR:PROJECT_SUMMARY               	Valley fever, and cases are on the rise. The current diagnostics for Valley
PR:PROJECT_SUMMARY               	fever are severely lacking due to invasiveness (biopsy) and poor sensitivity
PR:PROJECT_SUMMARY               	(serology), strongly contributing to an unacceptable 23-day median
PR:PROJECT_SUMMARY               	time-to-diagnosis. There is a critical need for sensitive and non-invasive
PR:PROJECT_SUMMARY               	diagnostics for identifying Valley fever lung infections. Our long-term goal is
PR:PROJECT_SUMMARY               	to substantially shorten the time-to-diagnosis for Valley fever through the
PR:PROJECT_SUMMARY               	development of sensitive and specific breath-based diagnostics for
PR:PROJECT_SUMMARY               	coccidioidomycosis lung infections. The overall objective of this application is
PR:PROJECT_SUMMARY               	to identify and validate putative volatile biomarkers of Coccidioides infections
PR:PROJECT_SUMMARY               	via metabolomics analyses of in vitro cultures, mouse model lung infections, and
PR:PROJECT_SUMMARY               	lung specimens from humans with Valley fever. At the completion of the proposed
PR:PROJECT_SUMMARY               	study, we expect to have identified and validated a panel of 10-15 volatile
PR:PROJECT_SUMMARY               	biomarkers for the sensitive and specific detection of valley fever in lung
PR:PROJECT_SUMMARY               	specimens.
PR:INSTITUTE                     	Arizona State University
PR:DEPARTMENT                    	School of Life Sciences
PR:LABORATORY                    	Bean Laboratory
PR:LAST_NAME                     	Bean
PR:FIRST_NAME                    	Heather
PR:ADDRESS                       	PO Box 874501, Tempe, AZ, 85287, USA
PR:EMAIL                         	Heather.D.Bean@asu.edu
PR:PHONE                         	480-727-3395
PR:FUNDING_SOURCE                	Arizona Biomedical Research Centre New Investigator Award to HDB
PR:PROJECT_COMMENTS              	Add to Project ID: PR001064
#STUDY
ST:STUDY_TITLE                   	Identify putative volatile biomarkers of Valley fever using a murine lung
ST:STUDY_TITLE                   	infection model (Human studies)
ST:STUDY_SUMMARY                 	Coccidioides immitis and Coccidioides posadasii are soil-dwelling fungi of arid
ST:STUDY_SUMMARY                 	regions in North and South America that are responsible for Valley fever
ST:STUDY_SUMMARY                 	(coccidioidomycosis). Forty percent of patients with Valley fever exhibit
ST:STUDY_SUMMARY                 	symptoms ranging from mild, self-limiting respiratory infections, to severe,
ST:STUDY_SUMMARY                 	life-threatening pneumonia that requires treatment. Misdiagnosis as bacterial
ST:STUDY_SUMMARY                 	pneumonia commonly occurs in symptomatic Valley fever cases, resulting in
ST:STUDY_SUMMARY                 	inappropriate treatment with antibiotics, increased medical costs, and delay in
ST:STUDY_SUMMARY                 	diagnosis. In this study, we explored the feasibility of developing breath-based
ST:STUDY_SUMMARY                 	diagnostics for Valley fever using lung specimens from persons with
ST:STUDY_SUMMARY                 	community-acquired pneumonia (CAP). To investigate potential volatile biomarkers
ST:STUDY_SUMMARY                 	of Valley fever that arise from host-pathogen interactions, we collected
ST:STUDY_SUMMARY                 	bronchoalveolar lavage fluid (BALF) and sputum from patients treated at Mayo
ST:STUDY_SUMMARY                 	Clinic in Scottsdale, Arizona for untargeted volatile metabolomics via solid
ST:STUDY_SUMMARY                 	phase microextraction (SPME) and two-dimensional gas chromatography coupled to
ST:STUDY_SUMMARY                 	time-of-flight mass spectrometry (GC×GC-TOFMS). We identified 244 total
ST:STUDY_SUMMARY                 	volatile organic compounds (VOCs). Using Random Forest, we identified a subset
ST:STUDY_SUMMARY                 	of these VOCs that were also able to separate Coccidioides positive samples from
ST:STUDY_SUMMARY                 	bacteria positive samples. The data presented here show that Coccidioides and/or
ST:STUDY_SUMMARY                 	the host produce volatile metabolites that may yield biomarkers for a Valley
ST:STUDY_SUMMARY                 	fever breath test that can detect Coccidioidal infection.
ST:INSTITUTE                     	Arizona State University
ST:DEPARTMENT                    	School of Life Sciences
ST:LABORATORY                    	Bean Laboratory
ST:LAST_NAME                     	Bean
ST:FIRST_NAME                    	Heather
ST:ADDRESS                       	PO Box 874501
ST:EMAIL                         	Heather.D.Bean@asu.edu
ST:STUDY_TYPE                    	Untargeted metabolomics
ST:PHONE                         	4807273395
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
SU:GENDER                        	Male and female
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	Blank_1	Subject:Empty run | treatment:NA	RAW_FILE_NAME=Blank_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	Blank_2	Subject:Empty run | treatment:NA	RAW_FILE_NAME=Blank_2.SMP
SUBJECT_SAMPLE_FACTORS           	-	Blank_3	Subject:Empty run | treatment:NA	RAW_FILE_NAME=Blank_3.SMP
SUBJECT_SAMPLE_FACTORS           	-	Blank_4	Subject:Empty run | treatment:NA	RAW_FILE_NAME=Blank_4.SMP
SUBJECT_SAMPLE_FACTORS           	-	Blank_5	Subject:Empty run | treatment:NA	RAW_FILE_NAME=Blank_5.SMP
SUBJECT_SAMPLE_FACTORS           	-	Blank_6	Subject:Empty run | treatment:NA	RAW_FILE_NAME=Blank_6.SMP
SUBJECT_SAMPLE_FACTORS           	-	Blank_7	Subject:Empty run | treatment:NA	RAW_FILE_NAME=Blank_7.SMP
SUBJECT_SAMPLE_FACTORS           	-	Blank_8	Subject:Empty run | treatment:NA	RAW_FILE_NAME=Blank_8.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-100A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-100A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-100B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-100B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-100C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-100C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-102A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-102A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-102B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-102B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-102C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-102C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-108A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-108A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-108B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-108B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-108C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-108C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-109A_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-109A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-109B_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-109B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-109C_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-109C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-10A_1	Subject:Human BALF | treatment:Multi; Cocci+ NTM + bacterial	RAW_FILE_NAME=MNBAL-10A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-10B_1	Subject:Human BALF | treatment:Multi; Cocci+ NTM + bacterial	RAW_FILE_NAME=MNBAL-10B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-10C_1	Subject:Human BALF | treatment:Multi; Cocci+ NTM + bacterial	RAW_FILE_NAME=MNBAL-10C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-111A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-111A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-111B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-111B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-111C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-111C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-115A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-115A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-115B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-115B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-115C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-115C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-116A_1	Subject:Human BALF | treatment:Multi; Fungal + NTM	RAW_FILE_NAME=MNBAL-116A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-116B_1	Subject:Human BALF | treatment:Multi; Fungal + NTM	RAW_FILE_NAME=MNBAL-116B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-116C_1	Subject:Human BALF | treatment:Multi; Fungal + NTM	RAW_FILE_NAME=MNBAL-116C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-119A_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-119A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-119B_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-119B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-119C_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-119C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-120A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-120A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-120B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-120B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-120C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-120C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-129A_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-129A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-129B_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-129B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-129C_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-129C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-131A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-131A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-131B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-131B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-131C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-131C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-132A_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-132A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-132B_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-132B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-132C_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-132C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-136A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-136A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-136B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-136B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-136C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-136C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-14A_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-14A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-14B_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-14B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-14C_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-14C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-152A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-152A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-152B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-152B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-152C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-152C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-153A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-153A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-153B_2xprep_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-153B_2xprep_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-153C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-153C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-154A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-154A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-154B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-154B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-154C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-154C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-161A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-161A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-161B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-161B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-161C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-161C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-164A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-164A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-164B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-164B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-164C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-164C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-165A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-165A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-165B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-165B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-165C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-165C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-166A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-166A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-166B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-166B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-166C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-166C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-16A_1	Subject:Human BALF | treatment:Multi; Bacterial + viral	RAW_FILE_NAME=MNBAL-16A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-16B_1	Subject:Human BALF | treatment:Multi; Bacterial + viral	RAW_FILE_NAME=MNBAL-16B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-16C_1	Subject:Human BALF | treatment:Multi; Bacterial + viral	RAW_FILE_NAME=MNBAL-16C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-17A_1	Subject:Human BALF | treatment:Fungal	RAW_FILE_NAME=MNBAL-17A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-17B_1	Subject:Human BALF | treatment:Fungal	RAW_FILE_NAME=MNBAL-17B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-17C_1	Subject:Human BALF | treatment:Fungal	RAW_FILE_NAME=MNBAL-17C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-188A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-188A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-188B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-188B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-188C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-188C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-192A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-192A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-192B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-192B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-192C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-192C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-193A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-193A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-193B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-193B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-193C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-193C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-198A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-198A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-198B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-198B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-198C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-198C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-208A_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-208A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-208B_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-208B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-208C_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-208C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-212A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-212A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-212B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-212B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-212C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-212C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-223A_1	Subject:Human BALF | treatment:Z; Unknown	RAW_FILE_NAME=MNBAL-223A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-223B_1	Subject:Human BALF | treatment:Z; Unknown	RAW_FILE_NAME=MNBAL-223B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-28A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-28A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-28B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-28B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-28C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-28C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-32A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-32A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-32B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-32B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-32C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-32C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-33A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-33A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-33B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-33B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-33C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-33C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-39A_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-39A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-39B_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-39B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-39C_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-39C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-3A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-3A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-3B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-3B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-3C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-3C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-41A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-41A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-41B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-41B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-41C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-41C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-49A_1	Subject:Human BALF | treatment:Multi; Cocci + bacterial	RAW_FILE_NAME=MNBAL-49A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-49B_1	Subject:Human BALF | treatment:Multi; Cocci + bacterial	RAW_FILE_NAME=MNBAL-49B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-49C_1	Subject:Human BALF | treatment:Multi; Cocci + bacterial	RAW_FILE_NAME=MNBAL-49C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-51A_1	Subject:Human BALF | treatment:Multi; Viral + Fungal + Bacterial	RAW_FILE_NAME=MNBAL-51A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-51B_1	Subject:Human BALF | treatment:Multi; Viral + Fungal + Bacterial	RAW_FILE_NAME=MNBAL-51B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-51C_1	Subject:Human BALF | treatment:Multi; Viral + Fungal + Bacterial	RAW_FILE_NAME=MNBAL-51C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-53A_1	Subject:Human BALF | treatment:Multi; Bacterial + Viral + Fungal	RAW_FILE_NAME=MNBAL-53A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-53B_1	Subject:Human BALF | treatment:Multi; Bacterial + Viral + Fungal	RAW_FILE_NAME=MNBAL-53B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-5A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-5A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-5B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-5B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-61A_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-61A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-61B_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-61B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-67A_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-67A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-67B_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-67B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-67C_1	Subject:Human BALF | treatment:Viral	RAW_FILE_NAME=MNBAL-67C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-71A_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-71A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-71B_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-71B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-71C_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-71C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-72A_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-72A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-72B_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-72B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-73A_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-73A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-73B_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-73B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-73C_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-73C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-74A_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-74A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-74B_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-74B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-74C_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-74C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-75A_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-75A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-75B_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-75B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-75C_1	Subject:Human BALF | treatment:Cocci	RAW_FILE_NAME=MNBAL-75C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-76A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-76A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-76B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-76B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-76C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-76C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-77A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-77A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-77B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-77B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-77C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-77C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-82A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-82A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-82B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-82B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-82C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-82C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-83A_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-83A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-83B_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-83B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-83C_1	Subject:Human BALF | treatment:Negative	RAW_FILE_NAME=MNBAL-83C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-97A_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-97A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-97B_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-97B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	MNBAL-97C_1	Subject:Human BALF | treatment:Bacterial	RAW_FILE_NAME=MNBAL-97C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	Pooled-1_1	Subject:Pooled BALF | treatment:Pooled	RAW_FILE_NAME=Pooled-1_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	Pooled-2_1	Subject:Pooled BALF | treatment:Pooled	RAW_FILE_NAME=Pooled-2_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	Pooled-3_1	Subject:Pooled BALF | treatment:Pooled	RAW_FILE_NAME=Pooled-3_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	Pooled-4_1	Subject:Pooled BALF | treatment:Pooled	RAW_FILE_NAME=Pooled-4_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	Pooled-5_1	Subject:Pooled BALF | treatment:Pooled	RAW_FILE_NAME=Pooled-5_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R721A_1	Subject:Human Bronchial Wash | treatment:Fungal	RAW_FILE_NAME=R721A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R721B_1	Subject:Human Bronchial Wash | treatment:Fungal	RAW_FILE_NAME=R721B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R721C_1	Subject:Human Bronchial Wash | treatment:Fungal	RAW_FILE_NAME=R721C_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R744A_1	Subject:Human Bronchial Wash | treatment:Cocci	RAW_FILE_NAME=R744A_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R744B_1	Subject:Human Bronchial Wash | treatment:Cocci	RAW_FILE_NAME=R744B_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R814aA_2xprep_1	Subject:Human Sputum (tracheal secretions) | treatment:Bacterial + Viral	RAW_FILE_NAME=R814aA_2xprep_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R814aB_1	Subject:Human Sputum (tracheal secretions) | treatment:Bacterial + Viral	RAW_FILE_NAME=R814aB_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R814aC_1	Subject:Human Sputum (tracheal secretions) | treatment:Bacterial + Viral	RAW_FILE_NAME=R814aC_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R815aA_1	Subject:Human Sputum (tracheal secretions) | treatment:Cocci	RAW_FILE_NAME=R815aA_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R815aB_1	Subject:Human Sputum (tracheal secretions) | treatment:Cocci	RAW_FILE_NAME=R815aB_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R815bA_1	Subject:Human Bronchial Wash | treatment:Multi; Viral + bacterial (maybe cocci)	RAW_FILE_NAME=R815bA_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R815bB_1	Subject:Human Bronchial Wash | treatment:Multi; Viral + bacterial (maybe cocci)	RAW_FILE_NAME=R815bB_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R815bC_1	Subject:Human Bronchial Wash | treatment:Multi; Viral + bacterial (maybe cocci)	RAW_FILE_NAME=R815bC_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R816aA_1	Subject:Human Sputum | treatment:Cocci	RAW_FILE_NAME=R816aA_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R816aB_1	Subject:Human Sputum | treatment:Cocci	RAW_FILE_NAME=R816aB_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R820aA_1	Subject:Human Sputum (induced) | treatment:Cocci	RAW_FILE_NAME=R820aA_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R820aB_1	Subject:Human Sputum (induced) | treatment:Cocci	RAW_FILE_NAME=R820aB_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R823aA_1	Subject:Human Bronchial Wash | treatment:Cocci	RAW_FILE_NAME=R823aA_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R823aB_1	Subject:Human Bronchial Wash | treatment:Cocci	RAW_FILE_NAME=R823aB_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R823aC_1	Subject:Human Bronchial Wash | treatment:Cocci	RAW_FILE_NAME=R823aC_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R824aA_1	Subject:Human Sputum (induced) | treatment:Cocci	RAW_FILE_NAME=R824aA_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	R824aB_1	Subject:Human Sputum (induced) | treatment:Cocci	RAW_FILE_NAME=R824aB_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	Standard mix_1	Subject:Alkane Standard and Grob Mix | treatment:Standard Mix	RAW_FILE_NAME=Standard mix_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	Standard_1	Subject:Alkane Standard and Grob Mix | treatment:Standard Mix	RAW_FILE_NAME=Standard_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	Standard_mix_1	Subject:Alkane Standard and Grob Mix | treatment:Standard Mix	RAW_FILE_NAME=Standard_mix_1.SMP
SUBJECT_SAMPLE_FACTORS           	-	Standard_mix_2	Subject:Alkane Standard and Grob Mix | treatment:Standard Mix	RAW_FILE_NAME=Standard_mix_2.SMP
SUBJECT_SAMPLE_FACTORS           	-	Standard_mix_3	Subject:Alkane Standard and Grob Mix | treatment:Standard Mix	RAW_FILE_NAME=Standard_mix_3.SMP
#COLLECTION
CO:COLLECTION_SUMMARY            	Human lung specimens were collected and stored in -80'C at Mayo Clinic in
CO:COLLECTION_SUMMARY            	Scottsdale, Arizona until they were transferred to Arizona State University for
CO:COLLECTION_SUMMARY            	VOCs analysis
CO:SAMPLE_TYPE                   	Bronchoalveolar lavage
#TREATMENT
TR:TREATMENT_SUMMARY             	55 bronchoalveolar lavage fluid (BALF), four bronchial wash, and five sputum
TR:TREATMENT_SUMMARY             	samples were provided by Tom Gris at Mayo Clinic, Scottsdale, Arizona. Patient
TR:TREATMENT_SUMMARY             	samples were categorized by infecting microbial organisms; Coccidioides, fungal,
TR:TREATMENT_SUMMARY             	bacterial, viral, multiple, and, non-infectious using hospital codes and doctors
TR:TREATMENT_SUMMARY             	notes. A sample was considered Coccidioides positive if it had a positive
TR:TREATMENT_SUMMARY             	serology test or was confirmed by culture. Fungal samples were either
TR:TREATMENT_SUMMARY             	Coccidioides positive or had a positive fungal culture or fungal smear.
TR:TREATMENT_SUMMARY             	Bacterial samples were identified by gram stain, bacterial culture, or PCR.
TR:TREATMENT_SUMMARY             	Samples were considered viral positive by PCR. If a sample was considered
TR:TREATMENT_SUMMARY             	positive for more than one type of infectious organism (ex, bacterial positive
TR:TREATMENT_SUMMARY             	and viral positive) it was labeled multiple. Samples that did not fit into an
TR:TREATMENT_SUMMARY             	infectious category, as described, they were labeled non-infectious.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	The BALF samples were allowed to thaw at 4°C overnight, and then split into
SP:SAMPLEPREP_SUMMARY            	technical triplicates of 200 μL that were transferred and sealed into
SP:SAMPLEPREP_SUMMARY            	sterilized 2 mL GC headspace vials with Supelco® PTFE/silicone septum magnetic
SP:SAMPLEPREP_SUMMARY            	screw caps (Sigma-Aldrich®, St. Louis, MO). All samples were stored in GC
SP:SAMPLEPREP_SUMMARY            	headspace vials for up to 14 d at -20°C until analyzed. Samples were randomized
SP:SAMPLEPREP_SUMMARY            	for analysis. Volatile metabolites sampling was performed by solid phase
SP:SAMPLEPREP_SUMMARY            	microextraction (SPME) using a Gerstel® MPS Robotic Pro MultiPurpose
SP:SAMPLEPREP_SUMMARY            	autosampler directed by Maestro® software (Gerstel®, Inc., Linthicum, MD).
SP:SAMPLEPREP_SUMMARY            	Volatile metabolite analysis was performed by two-dimensional gas
SP:SAMPLEPREP_SUMMARY            	chromatography−time-of-flight mass spectrometry (GC×GC–TOFMS) using a
SP:SAMPLEPREP_SUMMARY            	LECO® Pegasus® 4D and Agilent® 7890B GC (LECO® Corp., St. Joseph, MI). An
SP:SAMPLEPREP_SUMMARY            	external alkane standards mixture (C8 – C20; Sigma-Aldrich®) was sampled
SP:SAMPLEPREP_SUMMARY            	multiple times for calculating retention indices (RI). The injection,
SP:SAMPLEPREP_SUMMARY            	chromatographic, and mass spectrometric methods for analyzing the alkane
SP:SAMPLEPREP_SUMMARY            	standards were the same as for the samples.
SP:EXTRACTION_METHOD             	Solid-phase microextraction (SPME)
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	GCxGC
CH:INSTRUMENT_NAME               	Agilent 7890B
CH:COLUMN_NAME                   	Column 1: Rxi-624Sil MS, (60m × 0.25mm × 1.4um); Column 2: Stabilwax, (1m ×
CH:COLUMN_NAME                   	0.25mm × 0.5um)
CH:SOLVENT_A                     	NA
CH:SOLVENT_B                     	NA
CH:FLOW_GRADIENT                 	NA
CH:FLOW_RATE                     	2 mL∙min-1 (constant)
CH:COLUMN_TEMPERATURE            	230
CH:METHODS_FILENAME              	VF_human_GCxGC_methods.docx
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
AN:ANALYSIS_PROTOCOL_FILE        	VF_human_MS_methods.docx
#MS
MS:INSTRUMENT_NAME               	Leco Pegasus 4D GCxGC TOF
MS:INSTRUMENT_TYPE               	GC x GC-TOF
MS:MS_TYPE                       	EI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	See attached protocol
MS:MS_RESULTS_FILE               	ST002449_AN003997_Results.txt	UNITS:Peak areas	Has m/z:No	Has RT:Yes	RT units:Seconds
#END